Compare EVGN & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVGN | ACON |
|---|---|---|
| Founded | 1999 | 2008 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Retail: Computer Software & Peripheral Equipment |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1M | 5.0M |
| IPO Year | 2013 | 2022 |
| Metric | EVGN | ACON |
|---|---|---|
| Price | $0.28 | $1.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 39.2K | 16.2K |
| Earning Date | 11-19-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 99.82 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $75,730.00 |
| Revenue This Year | N/A | $44.55 |
| Revenue Next Year | $81.06 | $123.97 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 65.62 |
| 52 Week Low | $0.35 | $1.71 |
| 52 Week High | $1.28 | $9.36 |
| Indicator | EVGN | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 21.66 | 31.46 |
| Support Level | N/A | N/A |
| Resistance Level | $0.41 | $2.06 |
| Average True Range (ATR) | 0.02 | 0.09 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 7.95 | 20.54 |
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.